Thu, Apr 17, 2014, 6:21 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Hyperion Therapeutics, Inc. (HPTX) Message Board

  • rrtzrealmd rrtzrealmd Feb 28, 2013 6:24 PM Flag

    By the way, did anyone...

    ...notice the curious coincidence of the company announcing the availability of Ravicti almost simultaneously with filing the secondary -- you do recall that filing for 50 MILLION dollars that somehow neglects to include the price and number of shares to be offered?...

    ...but it looks like the announcemment didn't help the share price now, did it"...

    ...but the thing is, what with them now starting to roll in the dough --- what with the massive demand they expect for ravicti -- even though third party reimbursers likely won't pay for it since so far all HPTX can claim is "non-inferiority" to its competitor...

    ...well, anyway, as I was saying, they had around 50 MILLION dollars at the end of last year...and they only burned 28 MILLION last year -- and 17 MILLION of that was on R&D...

    ...although what on earth they are spending that R&DE on is beyond me...I mean, ravicti is already approved and according to their website the ONLY thing in their "pipeline" is -- well -- ravicti...

    ...so presuming therefore that they can start spending that 17 million on marketing instead, what exactly do they need 50 mMILLION more dollars for?...

    ...UNLESS, of course, they AREN'T expecting massive demand for ravicti and -- consequently -- AREN'T expecting any significant cah flow from sales...

    ...in which case, of course, they'll be needing that 50 MILLION dollars to pay management's salaries, benefits, bonuses, and salaries...

    ...yeah, that's about par for a biotech...HAW, HAW, HAW!!!...

    Sentiment: Strong Sell

 
HPTX
24.71-0.26(-1.04%)Apr 17 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.